Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JN Medsys
Singapore, Central Singapore, Singapore
- Ownership
- Private
- Development stage
- Other
01
Overview
The company commercializes a proprietary digital PCR platform and has clinically validated PCR-based kits, including for SARS-CoV-2 and Omicron variant detection, with reference customers in academia and healthcare[1][3].
- Therapeutic areas
- OncologyOtherInfectious Diseases
- Modalities
- DeviceDiagnostic tool
- Industry
- Molecular Diagnostics
02
Partnerships
Academic collaborations (e.g., National University of Singapore, National Cheng Kung University)specific corporate pharma partnerships not disclosed
Beyond the preview
Go deeper on JN Medsys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JN Medsys.